Tag: chemotherapy-induced peripheral neuropathy

A prospective cohort study found that plasma neurofilament light chain rose roughly fourfold during vincristine chemotherapy in adults with non-Hodgkin ...

A new meta-analysis finds that cooling gloves and socks during paclitaxel chemotherapy significantly reduce sensory nerve damage in breast cancer ...

A study of 563 patients receiving platinum chemotherapy shows that threatening illness perceptions drive CIPN symptom burden and distress largely ...

A new systematic review finds that duloxetine consistently reduces chemotherapy-induced peripheral neuropathy pain, while topical amitriptyline and combination therapies show ...

In the realm of oncology, a persistent challenge has been the long-term neurotoxic consequences faced by patients undergoing chemotherapy. While ...

Chemotherapy has revolutionized cancer treatment, significantly improving survival rates for many patients worldwide. However, its life-saving benefits often come at ...

A groundbreaking discovery by scientists at Wake Forest University School of Medicine, in collaboration with Weill Cornell Medicine, sheds critical ...

In the relentless battle against breast cancer, taxane-based chemotherapeutics have emerged as a frontline defense, boasting significant efficacy in halting ...

Chemotherapy-induced peripheral neuropathy (CIPN) remains one of the most challenging side effects faced by breast cancer patients undergoing taxane-based chemotherapy. ...

In a groundbreaking advance emerging from the Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center, researchers have uncovered a pivotal ...